Category | Brian injury group(n = 54) | Control group (n = 11) | P |
---|---|---|---|
Age | 47 ± 14 | 51 ± 14 | 0.321 |
Gender (male = n%) | 39 (72%) | 6 (54%) | 0.200 |
β2MG before HBOT | 2.64 ± 0.79 | 1.73 ± 0.39 | 0.001 |
β2MU before HBOT | 6.82 ± 20.2 | 0.17 ± 0.16 | 0.006 |
SCR before HBOT | 52 ± 14 | 64 ± 11 | 0.016 |
BUN before HBOT | 5.3 ± 2.2 | 4.3 ± 1.2 | 0.190 |
β2MG after 1st course HBOT | 2.58 ± 0.76 | 1.73 ± 0.39 | 0.002 |
β2MU after 1st course HBOT | 2.07 ± 7.46 | 0.17 ± 0.16 | 0.258 |
SCR after 1st course HBOT | 47 ± 16 | 64 ± 11 | 0.004 |
BUN after 1st course HBOT | 4.4 ± 1.4 | 4.3 ± 1.2 | 0.907 |
β2MG after 2nd course HBOT | 2.14 ± 0.66 | 1.73 ± 0.39 | 0.067 |
β2MU after 2nd course HBOT | 0.65 ± 2.09 | 0.17 ± 0.16 | 0.308 |
SCR after 2nd course HBOT | 47 ± 15 | 64 ± 11 | 0.004 |
BUN after 2nd course HBOT | 4.1 ± 1.3 | 4.3 ± 1.2 | 0.715 |